with Global Presence
Fosun Pharma USA Inc. established in 2017, is a subsidiary of a leading global healthcare group, Fosun Pharma (SSE: 600196) (SEHK:2196) and Fosun International Limited (SEHK: 656), a leading conglomerate and investment company.
The Fosun Pharma US Innovation Hub (FUSION) is our U.S.-based incubator that invests in preclinical stage initiatives under development at universities or research facilities.
FUSION extends Fosun Pharma’s corporate mission to continually develop innovative new products and talent to advance the accessibility of healthcare. FUSION is looking for preclinical programs that seek initial funding and fit the following general criteria:
Open to all therapeutic areas,
including but not limited to:
Open to all technology platforms and therapeutic modalities, including but not limited to: